Cancer-Causing Mutations Alter the Interplay Between Loop Dynamics and Catalysis in the Protein Tyrosine Phosphatases...

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Protein tyrosine phosphatases (PTPs) SHP-1 and SHP-2 are crucial drug targets due to their roles in cancer and other diseases.
• Despite similar active sites, SHP-1 and SHP-2 exhibit distinct biological functions and opposing roles in cancer.
• Both PTPs possess tandem Src homology 2 (SH2) domains that regulate catalytic activity via autoinhibition.

Purpose of the Study:

• To computationally investigate the dynamics of the WPD-loop in SHP-1 and SHP-2.
• To understand how oncogenic mutations affect WPD-loop dynamics and catalysis in these PTPs.
• To elucidate the role of SH2 domains in regulating catalytic loop motion and its differences between SHP-1 and SHP-2.

Main Methods:

• Detailed computational studies of WPD-loop dynamics and catalysis.
• Analysis of wild-type and mutant full-length and truncated SHP-1 and SHP-2.
• Molecular simulations to link SH2 domains, loop motion, and catalytic activity.

Main Results:

• Many oncogenic mutations identified on allosteric pathways directly impact WPD-loop dynamics.
• Mutations alter WPD-loop motion, leading to active site disruption and impaired catalysis.
• Simulations reveal how SH2 domains influence catalytic domain loop motion, with distinct mechanisms in SHP-1 versus SHP-2.

Conclusions:

• Altered WPD-loop motion is a key factor in oncogenic SHP-1 and SHP-2 variants.
• Understanding these dynamics opens new avenues for developing selective therapeutic agents targeting these enzymes.
• This research provides molecular insights into PTP regulation and its implications for cancer therapy.